Growth hormone deficiency in pseudohypoparathyroidism type 1a: Another manifestation of multihormone resistance

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 9, 2003, Pages 4059-4069

  Germain Lee, Emily L ^a,c   Groman, Joshua ^b   Crane, Janet L ^a   Jan De Beur, Suzanne M ^a   Levine, Michael A ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; LEVODOPA; PARATHYROID HORMONE; PROTEIN GNAS1; SOMATOMEDIN C; THYROTROPIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALBRIGHT SYNDROME; ARTICLE; BLOOD ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GROWTH HORMONE DEFICIENCY; HORMONE RESISTANCE; HUMAN; MALE; OBESITY; PRIORITY JOURNAL; PSEUDOHYPOPARATHYROIDISM; SHORT STATURE;

EID: 0141606268     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030028     Document Type: Article

References (77)

1. Levine MA 2002 Pseudohypoparathyroidism. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology. San Diego: Academic Press; 1137-1163
2. Weinstein LS, Yu S, Warner DR, Liu J 2001 Endocrine manifestations of stimulatory G protein α-subunit mutations and the role of genomic imprinting. Endocr Rev 22:675-705
3. Albright F, Burnett CH, Smith PH 1942 Pseudohypoparathyroidism: an example of "Seabright-Bantam syndrome." Endocrinology 30:922-932
4. Levine MA, Downs Jr RW, Moses AM, Breslau NA, Marx SJ, Lasker RD, Rizzoli RE, Aurbach GD, Spiegel AM 1983 Resistance to multiple hormones in patients with pseudohypoparathyroidism: association with deficient activity of guanine nucleotide regulatory protein. Am J Med 74:545-556
5. Brickman AS, Carlson HE, Levin SR 1986 Responses to glucagon infusion in pseudohypoparathyroidism. J Clin Endocrinol Metab 63:1354-1360
6. Albright F, Forbes AP, Henneman PH 1952 Pseudopseudohypoparathyroidism. Trans Assoc Am Physicians 65:337-350
7. Bastepe M, Juppner H 2000 Identification and characterization of two new, highly polymorphic loci adjacent to GNAS1 on chromosome 20q13.3. Mol Cell Probes 14:261-264
8. Wilson LC, Trembath RC 1994 Albright's hereditary osteodystrophy. J Med Genet 31:779-784 (Review)
9. Davies SJ, Hughes HE 1993 Imprinting in Albright's hereditary osteodystrophy. J Med Genet 30:101-103
10. s gene. Proc Natl Acad Sci USA 95:8715-8720
11. Klemke M, Pasolli HA, Kehlenbach RH, Offermanns S, Schultz G, Huttner WB 2000 Characterization of the extra-large G protein α-subunit XLαs. II. Signal transduction properties. J Biol Chem 275:33633-33640
12. Pasolli HA, Klemke M, Kehlenbach RH, Wang Y, Huttner WB 2000 Characterization of the extra-large G protein α-subunit XLαs. I. Tissue distribution and subcellular localization. J Biol Chem 275:33622-33632
13. Bastepe M, Gunes Y, Perez-Villamil B, Hunzelman J, Weinstein LS, Juppner H 2002 Receptor-mediated adenylyl cyclase activation through XLαs, the extra-large variant of the stimulatory G protein α-subunit. Mol Endocrinol 16:1912-1919
14. s in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1a. Biochem Biophys Res Commun 296:67-72
15. Liu J, Litman D, Rosenberg MJ, Yu S, Biesecker LG, Weinstein LS 2000 A GNAS1 imprinting defect in pseudohypoparathyroidism type 1b. J Clin Invest 106:1167-1174
16. Hayward BE, Moran V, Strain L, Bonthron DT 1998 Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins. Proc Natl Acad Sci USA 95:15475-15480
17. Hayward BE, Kamiya M, Strain L, Moran V, Campbell R, Hayashizaki Y, Bonthron DT 1998 The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins. Proc Natl Acad Sci USA 95:10038-10043
18. 5 signal transduction protein cDNA species. Nucleic Acids Res 17:4725-4729
19. Ischia R, Lovisetti-Scamihorn P, Hogue-Angeletti R, Wolkersdorfer M, Winkler H, Fischer-Colbrie R 1997 Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HT1B receptor antagonist activity. J Biol Chem 272:11657-11662
20. Hayward BE, Bonthron DT 2000 An imprinted antisense transcript at the human GNAS1 locus. Hum Mol Genet 9:835-841
21. s in the thyroid as the basis for TSH resistance in pseudohypoparathyroidism type 1a. Proc of the 24th Annual Meeting of the American Society for Bone and Mineral Research, San Antonio, TX, 2002, p S210 (Abstract, F389)
22. Palmiter RD, Brinster RL, Hammer RE, Trumbauer ME, Rosenfeld MG, Birnberg NC, Evans RM 1982 Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 300:611-615
23. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325:1688-1695
24. Scott DC, Hung W 1995 Pseudohypoparathyroidism type 1a and growth hormone deficiency in two siblings. J Pediatr Endocrinol Metab 8:205-207
25. Shima M, Nose O, Shimizu K, Seino Y, Yabuuchi H, Saito T 1988 Multiple associated endocrine abnormalities in a patient with pseudohypoparathyroidism type 1a. Eur J Pediatr 147:536-538
26. Wagar G, Lehtivuori J, Salven I, Backman R, Sivula A 1980 Pseudohypoparathyroidism associated with hypercalcitoninaemia. Acta Endocrinol (Copenh) 93:43-48
27. Marguet C, Mallet E, Basuyau JP, Martin D, Leroy M, Brunelle P 1997 Clinical and biological heterogeneity in pseudohypoparathyroidism syndrome. Results of a multicenter study. Horm Res 48:120-130
28. Urdanivia E, Mataverde A, Cohen MP 1975 Growth hormone secretion and sulfation factor activity in pseudohypoparathyroidism. J Lab Clin Med 86: 772-776
29. Suzuki H, Kasai K, Shimoda S, Mori K, Miyasaka M 1982 Improvement in abnormal secretion of thyrotropin and gonadotropin after restoration of serum calcium in pseudohypoparathyroidism. Endocrinol Jpn 29:69-75
30. Faull CM, Welbury RR, Paul B, Kendall-Taylor P 1991 Pseudohypoparathyroidism: its phenotypic variability and associated disorders in a large family. Q J Med 78:251-264
31. s gene GNAS1 in the pathogenesis of acromegaly. J Clin Invest 107:R31-R36
32. Sambrook J, Fritsch EF, Maniatis T 1989 Molecular cloning: a laboratory manual. 1st ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory
33. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA 1988 Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491
34. Miric A, Vechio JD, Levine MA 1993 Heterogeneous mutations in the gene encoding the α subunit of the stimulatory G protein of adenylyl cyclase in Albright hereditary osteodystrophy. J Clin Endocrinol Metab 76:1560-1568
35. Patten JL, Johns DR, Valle D, Eil C, Gruppuso PA, Steele G, Smallwood PM, Levine MA 1990 Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystropby. N Engl J Med 322:1412-1419
36. Jan de Beur SM, Deng Z, Ding CL, Levine MA, Amplification of the GC-rich exon 1 of GNAS1 and identification of three novel nonsense mutations in Albright's hereditary osteodystrophy. Program of the 80th Annual Meeting of The Endocrine Society, New Orleans, LA, 1998, p 62 (Abstract OR7-6)
37. s protein is the basis for Albright's Hereditary Osteodystrophy: lack of effect of NESP55 or XLαs deficiency on phenotype. Program of the 84th Annual Meeting of The Endocrine Society, San Francisco, CA, 2002, p 95 (Abstract OR22-6)
38. Bayley N, Pinneau SR 1952 Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr 40:423-441
39. 1998 AACE clinical practice guidelines for growth hormone use in adults and children. Endocr Pract 4:165-173
40. Sizonenko PC, Clayton PE, Cohen P, Hintz RL, Tanaka T, Laron Z 2001 Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 1: diagnosis of growth hormone deficiency. Growth Horm IGF Res 11:137-165
41. Allen D, Kleinberg D, Biller B, Cuneo R, Bengtsson B-Å, Melmed S, Blethen S, Hintz R 1998 The diagnosis and management of adult hormone deficiency. Clinical Courier 16:1-12
42. Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M, Bartolotta E, Dammacco F, Camanni F 1996 Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab 81:3323-3327
43. Maghnie M, Cavigioli F, Tinelli C, Autelli M, Arico M, Aimaretti G, Ghigo E 2002 GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset. J Clin Endocrinol Metab 87:2740-2744
44. Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E, Camanni F, Ghigo E 1998 Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 83:1615-1618
45. Gruelich WW, Pyle SI 1993 Radiographic atlas of skeletal development of the hand and wrist. Stanford, CA: Stanford University Press
46. Steinbach HL, Young DA 1966 The roentgen appearance of pseudohypoparathyroidism (PH) and pseudo-pseudohypoparathyroidism (PPH). Differentiation from other syndromes associated with short metacarpals, metatarsals, and phalanges. Am J Roentgenol Radium Ther Nucl Med 97:49-66
47. s mutant in a patient with Albright hereditary osteodystrophy uncouples cell surface receptors from adenylyl cyclase. J Biol Chem 269:25387-25391
48. Bastepe M, Pincus JE, Sugimoto T, Tojo K, Kanatani M, Azuma Y, Kruse K, Rosenbloom AL, Koshiyama H, Juppner H 2001 Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type 1b and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted GNAS1 locus. Hum Mol Genet 10:1231-1241
49. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL 2000 CDC Growth charts: Urdted States. Advanced data from vital and health statistics: no. 314. Hyattsville, MD: National Center for Health Statistics
50. Lindsay R, Feldkamp M, Harris D, Robertson J, Rallison M 1994 Utah growth study: growth standards and the prevalence of growth hormone deficiency. J Pediatr 125:29-35
51. Vimpani GV, Vimpani AF, Lidgard GP, Cameron EH, Farquhar JW 1977 Prevalence of severe growth hormone deficiency. Br Med J 2:427-430
52. Bao XL, Shi YF, Du YC, Liu R, Deng JY, Gao SM 1992 Prevalence of growth hormone deficiency of children in Beijing. Chin Med J (Engl) 105:401-405
53. Tani N 1985 [Epidemiologic study of dwarfism in Niigata Prefecture]. Nippon Naibunpi Gakkai Zasshi 61:1295-1309
54. de Mel T, Warnasooriya N, Fonseka C 1991 Growth hormone deficiency in Sri Lanka: a preliminary study. Ceylon Med J 36:95-97
55. s gene: predominant maternal origin of transcription in human thyroid gland and gonads. J Clin Endocrinol Metab 87:4736-4740
56. Aldred MA, Trembath RC 2000 Activating and inactivating mutations in the human GNAS1 gene. Hum Mutat 16:183-189
57. Fischer-Colbrie R, Eder S, Lovisetti-Scamihorn P, Becker A, Laslop A 2002 Neuroendocrine secretory protein 55: a novel marker for the constitutive secretory pathway. Ann N Y Acad Sci 971:317-322
58. Gasperi M, Cecconi E, Grasso L, Bartalena L, Centoni R, Aimaretti G, Broglio F, Miccoli P, Marcocci C, Ghigo E, Martino E 2002 GH secretion is impaired in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 87: 1961-1964
59. Nagant de Deuxchaisnes C, Krane SM 1978 Hypoparathyroidism. In: Avioli LV, Krane SM, eds. Metabolic bone disease. Vol 2. New York: Academic Press; 217-445
60. de Wijn EM, Steendijk R 1982 Growth and maturation in pseudo-hypoparathyroidism: a longitudinal study in 5 patients. Acta Endocrinol (Copenh) 101:223-226
61. Werder EA 1979 Pseudohypoparathyroidism. Ergeb Inn Med Kinderheilkd 42:191-221
62. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, Kronenberg HM, Mulligan RC 1994 Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8:277-289
63. Weir EC, Philbrick WM, Amling M, Neff LA, Baron R, Broadus AE 1996 Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci USA 93:10240-10245
64. Amizuka N, Warshawsky H, Henderson JE, Goltzman D, Karaplis AC 1994 Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J Cell Biol 126:1611-1623
65. Guo J, Lanske B, Liu BY, Divieti P, Kronenberg HM, Bringhurst FR 2001 Signal-selectivity of parathyroid hormone (PTH)/PTH-related peptide receptor-mediated regulation of differentiation in conditionally immortalized growth-plate chondrocytes. Endocrinology 142:1260-1268
66. Miao D, He B, Karaplis AC, Goltzman D 2002 Parathyroid hormone is essential for normal fetal bone formation. J Clin Invest 109:1173-1182
67. Kobayashi T, Chung UI, Schipani E, Starbuck M, Karsenty G, Katagiri T, Goad DL, Lanske B, Kronenberg HM 2002 PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps. Development 129:2977-2986
68. Jobert AS, Zhang P, Couvineau A, Bonaventure J, Roume J, Le Merrer M, Silve C 1998 Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest 102:34-40
69. Zhang P, Jobert AS, Couvineau A, Silve C 1998 A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia. J Clin Endocrinol Metab 83: 3365-3368
70. Lanske B, Karaplis AC, Lee K, Luz A, Vortkamp A, Pirro A, Karperien M, Defize LHK, Ho C, Mulligan RC, Abou-Samra AB, Juppner H, Segre GV, Kronenberg HM 1996 PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273:663-666
71. McCready ME, Sweeney E, Fryer AE, Donnai D, Baig A, Racacho L, Warman ML, Hunter AG, Bulman DE 2002 A novel mutation in the IHH gene causes brachydactyly type A1: a 95-year-old mystery resolved. Hum Genet 111: 368-375
72. Scacchi M, Pincelli AI, Cavagnini F 1999 Growth hormone in obesity. Int J Obes Relat Metab Disord 23:260-271
73. Yu S, Gavrilova O, Chen H, Lee R, Liu J, Pacak K, Parlow AF, Quon MJ, Reitman ML, Weinstein LS 2000 Paternal versus maternal transmission of a stimulatory G-protein α subunit knockout produces opposite effects on energy metabolism. J Clin Invest 105:615-623
74. Grosso S, Cioni M, Buoni S, Peruzzi L, Pucci L, Berardi R 1998 Growth hormone secretion in Prader-Willi syndrome. J Endocrinol Invest 21:418-422
75. Thacker MJ, Hainline B, Dennis-Feezle L, Johnson NB, Pescovitz OH 1998 Growth failure in Prader-Willi syndrome is secondary to growth hormone deficiency. Horm Res 49:216-220
76. Eiholzer U, Stutz K, Weinmann C, Torresani T, Molinari L, Prader A 1998 Low insulin, IGF-1 and IGFBP-3 levels in children with Prader-Labhart-Willi syndrome. Eur J Pediatr 157:890-893
77. 2000 Prader-Willi syndrome in the new millennium. The Endocrinologist 10(Suppl 1):1S-74S